AWM
CHRS icon

AllSquare Wealth Management’s Coherus Oncology CHRS Stock Holding History

AllSquare Wealth Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$26 Hold
16
– – ﹤0.01% 531
2025
Q2 		$12 Hold
16
– – ﹤0.01% 533
2025
Q1 		$13 Hold
16
– – ﹤0.01% 531
2024
Q4 		$22 Hold
16
– – ﹤0.01% 532
2024
Q3 		$17 Hold
16
– – ﹤0.01% 535
2024
Q2 		$28 Hold
16
– – ﹤0.01% 529
2024
Q1 		$38 Hold
16
– – ﹤0.01% 528
2023
Q4 		$53 Hold
16
– – ﹤0.01% 526
2023
Q3 		$60 Buy
+16
New +$74 ﹤0.01% 530

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AllSquare Wealth Management's CHRS Position: Q3 2025 in Review

AllSquare Wealth Management held its Coherus Oncology (CHRS) position steady in Q3 2025 at 16 shares worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #531.

AllSquare Wealth Management first reported a position in CHRS in Q3 2023 and has held it in 9 quarters since. The position peaked at $60 in Q3 2023. 114 funds tracked by Wall St. Rank hold CHRS as of Q3 2025.

  • AllSquare Wealth Management held 16 shares of Coherus Oncology worth $26 as of Q3 2025.
  • AllSquare Wealth Management left its Coherus Oncology share count unchanged in Q3 2025.
  • Coherus Oncology made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #531 holding.
  • AllSquare Wealth Management first reported a position in Coherus Oncology in Q3 2023 and has held it in 9 quarters since.
  • AllSquare Wealth Management's Coherus Oncology position peaked at $60 in Q3 2023.
  • 114 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.